Anticoagulation in Conventional Versus Transesophageal Echocardiography (TEE) Guided Cardioversion (CV) of Atrial Fibrillation (AF)

摘要

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia arid is associated with thrombembolic events and hemodynamic impairment that results in considerable morbidity, mortality and cost. Current guidelines recommend that patients receive anticoagulants for 3-4 weeks before and 4 weeks after cardioversion (CV). Transesophageal echocardiography (TEE) guided cardioversion with low-molecular-weight heparin (LMWH) may reduce the duration of anticoagulation.